Maintain your finger on our pulse – hottest CAMH information, discoveries and ways to become involved delivered to your inbox. Our history—evolving from an asylum into a modern wellness facility with sufferers for the centre of care—would be the heritage of mental health care in

In September 2013, the FDA launched new labeling rules for extended acting and prolonged release opioids requiring suppliers to get rid of average discomfort as sign for use, in its place stating the drug is for "soreness significant ample to demand everyday, about-the-clock, lasting opioid